NCT00896597View on ClinicalTrials.gov

Reproducibility of Child-Turcotte-Pugh (CTP) Rating and NRL972 Pharmacokinetics in Patients With Cirrhosis

PHASE1CompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

December 31, 2009

Conditions

Hepatic Cirrhosis

Interventions

DRUG

NRL972

2 mg NRL972 in 5 mL solution for injection administered as a 15-second intravenous injection on each of four occasions.

Trial Locations (1)

300244

IFE Romania, Timișoara

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Norgine

INDUSTRY

NCT00896597 - Reproducibility of Child-Turcotte-Pugh (CTP) Rating and NRL972 Pharmacokinetics in Patients With Cirrhosis | Biotech Hunter | Biotech Hunter